D Attri1, A N Nagarkar. 1. Speech and Hearing Unit, Department of Otolaryngology-Head and Neck Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Abstract
INTRODUCTION: Hyperacusis may be described as a decreased threshold for discomfort from sound. It may have a serious impact on an individual's lifestyle, as a result of decreased sociability and inability to spend time with family and friends due to intolerance of sound. SUBJECT: We present a case of hyperacusis associated with depression, with no other audiological abnormality. The patient reported greater difficulty during the depressive episode. METHOD: Audiological investigation was undertaken, followed by counselling and medication for depression. RESULTS AND CONCLUSION: The pathophysiological mechanism of hyperacusis in depression is discussed. Outcomes following treatment with directive counselling and lithium (an antidepressant) are described. Research indicates that both hyperacusis and depression can be caused by hypoactivity of 5-hydroxytryptamine (also known as serotonin) in the brain. The patient reported improvement which cannot be explained solely on the basis of counselling. Enhancement of serotonin activity due to lithium, prescribed for depression, may also play a role in alleviation of hyperacusis.
INTRODUCTION:Hyperacusis may be described as a decreased threshold for discomfort from sound. It may have a serious impact on an individual's lifestyle, as a result of decreased sociability and inability to spend time with family and friends due to intolerance of sound. SUBJECT: We present a case of hyperacusis associated with depression, with no other audiological abnormality. The patient reported greater difficulty during the depressive episode. METHOD: Audiological investigation was undertaken, followed by counselling and medication for depression. RESULTS AND CONCLUSION: The pathophysiological mechanism of hyperacusis in depression is discussed. Outcomes following treatment with directive counselling and lithium (an antidepressant) are described. Research indicates that both hyperacusis and depression can be caused by hypoactivity of 5-hydroxytryptamine (also known as serotonin) in the brain. The patient reported improvement which cannot be explained solely on the basis of counselling. Enhancement of serotonin activity due to lithium, prescribed for depression, may also play a role in alleviation of hyperacusis.
Authors: Kathryn Fackrell; Iskra Potgieter; Giriraj S Shekhawat; David M Baguley; Magdalena Sereda; Derek J Hoare Journal: Biomed Res Int Date: 2017-10-09 Impact factor: 3.411
Authors: Kathryn Fackrell; Linda Stratmann; Veronica Kennedy; Carol MacDonald; Hilary Hodgson; Nic Wray; Carolyn Farrell; Mike Meadows; Jacqueline Sheldrake; Peter Byrom; David M Baguley; Rosie Kentish; Sarah Chapman; Josephine Marriage; John Phillips; Tracey Pollard; Helen Henshaw; Toto A Gronlund; Derek J Hoare Journal: BMJ Open Date: 2019-11-21 Impact factor: 3.006